专题:Pancreatic Islet Dysfunction and Regeneration

This cluster of papers focuses on the dysfunction and regeneration of pancreatic islets, particularly related to ß-cell deficit, insulin secretion, diabetes mellitus, islet transplantation, glucose homeostasis, stem cell differentiation, oxidative stress, and pancreas development. The research covers various aspects of pancreatic islet biology and potential therapeutic approaches for addressing islet dysfunction in diabetes.
最新文献
scRiskCell: A single‐cell framework for quantifying islet risk cells and their adaptive dynamics in type 2 diabetes

article Full Text OpenAlex

Graft-Versus-Host Disease

book-chapter Full Text OpenAlex

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes

article Full Text OpenAlex

A microbial amino-acid-conjugated bile acid, tryptophan-cholic acid, improves glucose homeostasis via the orphan receptor MRGPRE

article Full Text OpenAlex

Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0

article Full Text OpenAlex

Decoding the Liver-Heart Axis in Cardiometabolic Diseases

review Full Text OpenAlex

Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice

article Full Text OpenAlex

In Utero Exposure to Maternal Hyperglycemia and Offspring Type 2 Diabetes Genetic Risk Score Are Independently Associated With Risk of Impaired Glucose Tolerance in Youth

article Full Text OpenAlex

Ppp1r3b is a metabolic switch that shifts hepatic energy storage from lipid to glycogen

article Full Text OpenAlex

Repurposing glucose-lowering drugs for cancer therapy

review Full Text OpenAlex

近5年高被引文献
Empagliflozin in Heart Failure with a Preserved Ejection Fraction

article Full Text OpenAlex 3537 FWCI536.605

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

article Full Text OpenAlex 1873 FWCI363.358

Empagliflozin in Patients with Chronic Kidney Disease

article Full Text OpenAlex 1607 FWCI310.212

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

review Full Text OpenAlex 1077 FWCI35.383

Anti-obesity drug discovery: advances and challenges

review Full Text OpenAlex 775 FWCI26.919

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

article Full Text OpenAlex 684 FWCI133.454

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

review Full Text OpenAlex 683 FWCI33.88

Insulin Resistance: From Mechanisms to Therapeutic Strategies

review Full Text OpenAlex 654 FWCI14.982

Streptozotocin‐Induced Diabetic Models in Mice and Rats

article Full Text OpenAlex 616 FWCI111.094

The trans-ancestral genomic architecture of glycemic traits

article Full Text OpenAlex 592 FWCI69.369